Cardiovascular Journal of Africa: Vol 27 No 2 (March/April 2016)

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 2, March/April 2016

AFRICA

cytokines, chemokines and adhesion molecules in normal pregnancy

and preeclampsia determined by multiplex suspension array.

BMC

Immunol

2010;

: 59.

59. Saito S, Sakai M. Th1/Th2 balance in preeclampsia.

J Reprod Immunol

2003;

(2): 161–173.

60. Kumar A, Begum N, Prasad S, Agarwal S, Sharma S. IL-10, TNF-alpha

& IFN-gamma: potential early biomarkers for preeclampsia.

Cell

Immunol

2013;

283

(1–2): 70–74.

61. Peracoli JC, Bannwart-Castro CF, Romao M,

et al

. High levels of heat

shock protein 70 are associated with pro-inflammatory cytokines and

may differentiate early- from late-onset preeclampsia.

J Reprod Immunol

2013;

100

(2): 129–134.

62. Lau SY, Guild SJ, Barrett CJ,

et al

. Tumor necrosis factor-alpha,

interleukin-6, and interleukin-10 levels are altered in preeclampsia: a

systematic review and meta-analysis.

Am J Reprod Immunol

2013;

(5):

412–427.

63. Ajith A. The role of peripheral natural killer cells in immunocompro-

mised pre-eclamptic and normotensive pregnant black South Africans.

PhD dissertation, University of KwaZulu-Natal, Durban, 2016.

64. Pinheiro MB, Martins-Filho OA, Mota AP,

et al.

Severe preeclampsia

goes along with a cytokine network disturbance towards a systemic

inflammatory state.

Cytokine

2013;

(1): 165–173.

65. Laresgoiti-Servitje E. A leading role for the immune system in the patho-

physiology of preeclampsia.

J Leukoc Biol

2013;

(2): 247–257.

66. Caniggia I, Winter J, Lye SJ, Post M. Oxygen and placental development

during the first trimester: implications for the pathophysiology of pre-

eclampsia.

Placenta

2000;

(Suppl A): S25-30.

67. Yinon Y, Nevo O, Xu J, et al. Severe intrauterine growth restriction

pregnancies have increased placental endoglin levels: hypoxic regulation

via transforming growth factor-beta 3.

Am J Pathol

2008;

172

(1): 77-85.

68. Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised

view.

Placenta

2009;

(Suppl A): S38-42.

69. Tewksbury DA, Dart RA. High molecular weight angiotensinogen levels

in hypertensive pregnant women.

Hypertension

1982;

(5): 729–734.

70. Brown MA, Wang J, Whitworth JA. The renin–angiotensin–aldosterone

system in pre-eclampsia.

Clin Exp Hypertens

1997;

(5–6): 713–726.

71. Wenzel K, Rajakumar A, Haase H,

et al.

Angiotensin II type 1 recep-

tor antibodies and increased angiotensin II sensitivity in pregnant rats.

Hypertension

2011;

(1): 77–84.

72. Herse F, Verlohren S, Wenzel K,

et al

. Prevalence of agonistic autoan-

tibodies against the angiotensin II type 1 receptor and soluble fms-like

tyrosine kinase 1 in a gestational age-matched case study.

Hypertension

2009;

(2): 393–398.

73. Bobst SM, Day MC, Gilstrap LC, 3rd, Xia Y, Kellems RE. Maternal

autoantibodies from preeclamptic patients activate angiotensin recep-

tors on human mesangial cells and induce interleukin-6 and plasmi-

nogen activator inhibitor-1 secretion.

Am J Hypertens

2005;

(3):

330–336.

74. Xia Y, Kellems RE. Angiotensin receptor agonistic autoantibodies and

hypertension: preeclampsia and beyond.

Circ Res

2013;

113

(1): 78–87.

75. Papapetropoulos A, Pyriochou A, Altaany Z,

et al

. Hydrogen sulfide

is an endogenous stimulator of angiogenesis.

Proc Natl Acad Sci USA

2009;

106

(51): 21972–21977.

76. Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H(2)S as

a novel endogenous gaseous K(ATP) channel opener.

EMBO J

2001;

(21): 6008–6016.

77. You XJ, Xu C, Lu JQ,

et al

. Expression of cystathionine beta-synthase

and cystathionine gamma-lyase in human pregnant myometrium and

their roles in the control of uterine contractility.

PLoS One

2011;

(8):

e23788.

78. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace

JL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediat-

ed inflammation.

FASEB J

2006;

(12): 2118–2120.

79. Zhuo Y, Chen PF, Zhang AZ, Zhong H, Chen CQ, Zhu YZ.

Cardioprotective effect of hydrogen sulfide in ischemic reperfusion

experimental rats and its influence on expression of survivin gene.

Biol

Pharm Bull

2009;

(8): 1406–1410.

80. Holwerda KM, Bos EM, Rajakumar A,

et al.

Hydrogen sulfide produc-

ing enzymes in pregnancy and preeclampsia.

Placenta

2012;

(6):

518–521.

81. Wang K, Ahmad S, Cai M,

et al.

Dysregulation of hydrogen sulfide

producing enzyme cystathionine gamma-lyase contributes to maternal

hypertension and placental abnormalities in preeclampsia.

Circulation

2013;

127

(25): 2514–2522.

82. Wang K, Ahmad S, Cai M,

et al

. Response to letter regarding article,

‘Dysregulation of hydrogen sulfide (H

S) producing enzyme cystathio-

nine gamma-lyase (CSE) contributes to maternal hypertension and

placental abnormalities in preeclampsia’.

Circulation

2014;

129

(22):

e517–518.

83. Zhou Y, Gormley MJ, Hunkapiller NM,

et al

. Reversal of gene dysregu-

lation in cultured cytotrophoblasts reveals possible causes of preeclamp-

sia.

J Clin Invest

2013;

123

(7): 2862–2872.

84. Basso O. Re: ‘Abortion, changed paternity, and risk of preeclampsia in

nulliparous women’.

Am J Epidemiol

2003;

158

(8): 825.

85. Shamsi U, Saleem S, Nishter N. Epidemiology and risk factors of

preeclampsia; an overview of observational studies.

Al Ameen J Med

Sci

2013;

(4): 292–300.